Main description:

This third volume in the series Tumor Dormancy, Quiescence, and Senescence discusses the role of tumor dormancy and senescence in a number of diseases, including breast cancer, ovarian cancer and leukemia. The contents are organized under five subheadings: General Applications, Role in Breast Cancer, Role in Ovarian Cancer, Role in Leukemia and Role in Cardiovascular Disease. The first section includes basic information on the definition of dormancy, how cells become senescent and what they do, along with an appraisal of the current state of research on dormancy. Section Two explores dormancy in breast cancer, including the progression of hormone-dependent mammary tumors after dormancy. Section Three details the resistance of Type II ovarian tumors, in which the resistant tumor cell population persists after chemotherapy in a state of dormancy, with recurrent tumors arising upon transformation of such dormant cells back to malignant growth. This section explains how lineage, histological subtypes and grade influence the differential response of ovarian cancer resistance to platinum drugs. The fourth section explores leukemia, discussing regulation of the promyelocytic leukemia protein and its role in premature senescence. The final section explores the role of senescence and autophagy in age-related cardiovascular diseases and the observation that autophagy seems to retard cardiac senescence. Like the two preceding volumes in the series, Volume 3 stands out for its comprehensive approach, its roster of some 26 expert contributors representing seven different countries and its up-to-date review of leading-edge technology and methods.

Contents:

Preface

I. General Applications

1. Active, dormant, or on the path to elimination: what does a senescent cell do?

2. Hypoxia and tumor dormancy: can the two tango?

3. Progeriod syndromes: role of accelerated fibroblast senescence and p38 activation

4. Induction of cancer cells senescence: role of caffeic acid 3,4-dihydroxy-phenethyl ester

II. Role in breast cancer

5. Various factors contributing to tumor dormancy: therapeutic implications in breast cancer

6. Progression of hormone-dependent mammary tumors after dormancy: role of wnt pathway

III. Role in ovarian cancer

7. Chemoresistance, dormancy and recurrence in platinum drug therapy of ovarian cancers

8. The role of angiogenesis, growth arrest and autophagy in human ovarian cancer xenograft models for tumor dormancy

IV. Role in leukemia

9. Regulation of the promyelocytic leukemia protein and its role in premature senescence

V. Role in cardiovascular disease

10. Cardiac senescence and autophagy

Index.